title: The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer - A Systematic Review.
authors.affiliation: AIBILI, Coimbra, Portugal.
authors.forename: C
authors.initials: C
authors.lastname: Alves
authors.affiliation: AIBILI, Coimbra, Portugal.
authors.forename: D
authors.initials: D
authors.lastname: Mendes
authors.affiliation: Roche Farmaceutica Quimica, Amadora, Portugal.
authors.forename: S
authors.initials: S
authors.lastname: Andrade
authors.affiliation: University of Coimbra, Coimbra, Portugal.
authors.forename: Marques F
authors.initials: MF
authors.lastname: Batel